INTRODUCTION {#sec0005}
============

Nearly 50 million adults worldwide over the age of 65 years will develop dementia \[[@ref001]\], and among those, an estimated 50--93% will experience chronic pain \[[@ref003]\]. Dementia is a known risk factor for the under-treatment of pain \[[@ref006]\]. People with Alzheimer's disease (AD) receive less pain medication for similarly painful conditions when compared with cognitively intact older adults \[[@ref010]\]. Pain is a multidimensional experience arising from cognitive, sensory, and affective central nervous system processes involving multiple neuronal circuits and brain regions.

Furthermore, AD impacts brain structure, such as the hypothalamus and the prefrontal cortex which is responsible for affective pain \[[@ref006]\]. A potential cause of the under-treatment of pain in dementia patients is the lack of understanding about how dementia influences the psychophysiological factors of the pain experience \[[@ref006]\] and how these influences differ by sex in communicative people across the cognitive spectrum. Pain is the primary reason people seek medical attention, and more evidence is needed to understand the altered pain experience in AD patients as the prevalence of AD and related dementias is expected to triple over the next 30 years \[[@ref001]\].

Psychophysical studies of pain frequently report sex-related differences in the pain experience in cognitively healthy adults \[[@ref016]\]. These sex differences may change with age since the prevalence of chronic pain increases with age as the function of endogenous pain inhibitory systems declines \[[@ref019]\]. In cognitively healthy older adults, women tend to experience pain at a higher intensity and report pain more frequently than men \[[@ref015]\]. However, this relationship has not been demonstrated to exist across the cognitive spectrum.

Understanding patterns of pain responsivity across age, sex, and cognitive ability are essential given evidence of sex-associated differences in the psychophysical and neuropsychological processing of pain, the increased incidence of chronic pain in older adults, and the potential for undertreatment of pain in dementia. We have published several papers from the parent data set showing sex differences in cognitively healthy older adults \[[@ref023]\]. We have also shown sex differences in a pilot sample of people with dementia only \[[@ref024]\]. To extend upon this work, we now examine sex differences in pain across the cognitive spectrum. While several between-groups psychophysical studies on sex differences in pain appear in literature, there is a paucity of experimental pain research using a continuous measure of cognitive ability to predict pain outcomes across the cognitive spectrum. Understanding patterns of experimental pain responsivity across age, sex, and cognitive ability are essential given evidence of sex-associated differences in the psychophysical and neuropsychological processing of pain. This understanding may help to develop more effective treatment plans for the growing number of older adults experiencing chronic pain with comorbid dementia. Thus, we tested the hypothesis that sex differences in psychophysical processing of pain are significantly associated with increasing or decreasing levels of global cognition.

METHODS {#sec0010}
=======

Study design {#sec0015}
------------

This study is a secondary analysis of a cross-sectional parent study designed to compare the psychological response to thermal pain in older adults with and without dementia. Thus, the current methods have been previously published \[[@ref023]\]. The purpose of the current study was to examine sex differences in the association of cognitive impairment and thermal pain perception in verbally communicative older adults. Cognitive impairment, as assessed by the Mini-Mental State Examination (MMSE; range 0--30), was used as the primary covariate in our outcome analysis and included scores across the cognitive spectrum (no cognitive impairment to severe cognitive impairment).

The Vanderbilt University Institutional Review Board approved the parent study, and each participant, or legal surrogate when appropriate, provided written informed consent at the time of enrollment. Capacity to consent was assessed using the University of California San Diego Brief Assessment of Capacity to Consent (UBACC), that takes less than 5 minutes to complete. A UBACC score higher than 14.5 was required for informed consent, as this cut-off is 89% sensitive and 100% specific for determining capacity to consent for research \[[@ref027]\]. Individuals with UBACC scores less than or equal to 14.5 (i.e., those lacking decisional capacity) signed an assent document and a legal surrogate provided consent. All participants and legal surrogates who completed the study were compensated US\$100 for their time.

Participants {#sec0020}
------------

The recruitment and enrollment protocol of the parent study are previously published \[[@ref023]\]. Participants 65 years of age or older were recruited from the greater Nashville, Tennessee metropolitan area and enrolled over three years from 2012 to 2015. A clinical diagnosis of AD was verified based on documentation in the medical record of 1) neuropsychiatric evaluation, diagnostic MRI or PET, lack of other potential causes of memory loss; and 2) results of the evaluation with the MMSE, Montreal Cognitive Assessment, or the Functional Assessment Staging Scale. Cognitively healthy participants were recruited using a mass email, flyers, and recruitment presentations in healthcare facilities and local events.

Participants were excluded for the following reasons: the presence of a chronic pain diagnosis, daily use of opioid or non-opioid pain medication, upper extremity peripheral neuropathy, any current cancer diagnosis or treatment, previous stroke with residual deficit, Raynaud's Disease, unstable cardiac conditions, insulin-dependent diabetes, or current diagnosis of major depression.

Because the parent study included neuroimaging, additional exclusion criteria included claustrophobia, the presence of a pacemaker, ventricular shunt, or any implanted metal object not confirmed as 3 Tesla MRI compatible, multiple metal implants in the same extremity, or presence of movement disorders (e.g., Parkinson's disease, restless leg syndrome). Participants were required to be verbally communicative and able to provide a verbal pain rating.

Screening and enrollment {#sec0025}
------------------------

A two-part screening process included an initial telephone screening, followed by a one-hour visit to confirm eligibility either at the participant's place of residence or at the Vanderbilt University Medical Center. Before any data collection occurred, participants and the legal surrogate (when necessary) were allowed to experience the thermal pain stimulus and complete two practice psychophysics trials. Practice trials ensured that participants understood the directions and could respond appropriately. Evidence of an appropriate response included the ability to follow directions and vocalize pain.

Measures {#sec0030}
--------

A trained research assistant administered all study measures orally to participants to decrease subject and caregiver burden and to minimize missing data. Demographic measures included a detailed list of all medications and the Hollingshead Four-Factor Index of Socioeconomic Status (SES) \[[@ref028]\]. The Brief Pain Inventory Short Form (BPI-SF) was used to collect current and average daily pain \[[@ref029]\]. Depression and anxiety screens included the Geriatric Depression Scale-Short Form (GDS-15) \[[@ref030]\] and the state and trait forms of the Spielberger State-Trait Anxiety Inventory (STAI) \[[@ref031]\], respectively.

Thermal stimulation protocol {#sec0035}
----------------------------

Trained research assistants administered the psychophysical thermal stimulation assessment over approximately 30 minutes following a modified protocol of the experimental mechanical pressure pain protocol by Cole et al. \[[@ref013]\]. Two aspects of pain were assessed using the Medoc Pathway Pain and Sensory Evaluation System: the intensity, how strong the pain feels; and the unpleasantness, how unpleasant or disturbing the pain feels. A 30×30 mm Medoc thermode was attached to the thenar eminence of the right hand. The thermode was programmed to deliver a baseline temperature of 30°C with increasing heat at a rate of 1°C/s (max temperature = 48°C).

Participants were instructed to signal to stop the increasing heat when the participant felt 'warmth', 'mild pain', or 'moderate pain'. The temperatures at which each participant stopped the increasing heat at each percept were documented. Following the approach we have previously published \[[@ref023]\], pain intensity was evaluated using a 0--20 sensory numeric rating scale with anchors "warmth = 0", "mild pain = 5", and "moderate pain = 11". Unpleasantness was evaluated using a 0--20 unpleasantness scale with anchors "0 = neutral", "5 = slightly unpleasant", "8 = unpleasant", "11 = very unpleasant", "16 = intolerable", and "20 = extremely distressing." Participants were acclimated to the scales and then completed three trials at each temperature condition, and the average self-reported pain intensity and unpleasantness ratings across the trials used in our analyses.

Statistical analysis {#sec0040}
--------------------

Participant characteristics and study data collected on a continuous scale were summarized using median and inter-quartile range (IQR) due to lack of normality (Fischer test\> ±2.58). Frequency distributions summarized nominal and ordinal data. Comparisons between males and females were conducted using Mann-Whitney U tests (continuous) and Chi-Square Tests of Independence (nominal, ordinal). Cohen's d effect size indices were generated to summarize the magnitude of the gender effects. Associations of global cognition (MMSE scores) with the psychophysical reports (temperatures and ratings of unpleasantness) for males and females were generated using Pearson correlations. Differences between males and females in the strength and/or direction of those associations were tested using linear regressions. Each of the gender and MMSE distributions were mean centered and multiplied to create an interaction term that was entered into each regression, along with gender and MMSE as main effects, to test for differences between males and females in the association of MMSE with the respective psychophysical report used in the regression.

Before conducting these correlations and regressions, the skewed psychophysical distributions were transformed to normal. Such that at the warmth threshold, both temperature and unpleasantness values were rank transformed and at the mild and moderate pain thresholds, unpleasantness values were square-root transformed. For all analyses, a maximum alpha of 0.05 (*p* \< 0.05) was used for determining statistical significance.

RESULTS {#sec0045}
=======

Demographics {#sec0050}
------------

A total of 80 participants were in the parent study. For this analysis, three participants were excluded due to an MMSE score of less than 10 and one subject was excluded due to missing an MMSE score. The final sample consisted of males (*n* = 38) and females (*n* = 38) with a median age of 73 (IQR: 68--80). MMSE scores ranged from 11 to 30 (IQR: 20--30). Of the sample 84% were white. On the day of the study, very few participants reported any pain (median both average and now = 0) and fewer than 10% reported pain levels of greater than 2 (7 of 76, 9%). There were no statistically significant differences between males and females on any of the participant characteristics investigated including most importantly the distribution of MMSE scores (see [Table 1](#jad-70-jad190142-t001){ref-type="table"}).

###### 

Demographic and clinical characteristics of the participants

                      Total (N = 76)     Female (*n* = 38)     Male (*n* = 38)      *p*
  ---------------- -------------------- -------------------- -------------------- -------
  Race                    N (%)                N (%)                N (%)          0.529
    White                64 (84)              31 (82)              33 (878)       
                    **Median \[IQR\]**   **Median \[IQR\]**   **Median \[IQR\]**  
  Age                  73\[68,80\]          73 \[68,80\]         73\[67,81\]       0.731
  MMSE^1^              28 \[20,30\]         27 \[21,30\]         28\[18,30\]       0.887
  BPI Average^2^        0 \[0,2\]            0 \[0,3\]            0 \[0,2\]        0.298
  BPI Now^2^            0 \[0,0\]            0 \[0,0\]            0 \[0,0\]        0.893
  GDS^3^                1 \[0,4\]            2 \[0,4\]            1 \[0,3\]        0.929
  STAI State^4^        48 \[44,50\]         50 \[45,53\]         47 \[45,50\]      0.105
  STAI Trait^4^        47 \[44,50\]         47 \[43,50\]         47 \[44,49\]      0.877
  SES^5^               54 \[41,61\]         53 \[38,58\]         55 \[45,62\]      0.324

^1^MMSE, Folstein Mini Mental State Examination (range = 0--30; 0 = completely cognitively impaired 30 = completely cognitively intact). ^2^BPI-SF, Brief Pain Inventory Short Form (range = 0--10; 0 = no pain, 10 = most pain). ^3^GDS-SF, Geriatric Depression Scale Short Form (range; 0 = no indication of depression, 15 = high possibility of depression); Female: *n* = 37, Male: *n* = 37. ^4^STAI, Spielberger State or Trait Anxiety Inventory (range; 20 = indicates increased anxiety, 80 = indicates least amount of anxiety); Female: *n* = 34, Male: *n* = 32. ^5^Hollingshead Four Factor Measure of Socio-Economic Status (range = 8--66; 8 = lowest SES, 66 = highest SES) Female: *n* = 38, Male: *n* = 36.

###### 

Distribution of MMSE by gender groups

  MMSE                             Female        Male
  ----------------------------- ------------ ------------
                                 (*n* = 38)   (*n* = 38)
  Cognitively Intact (29--30)        14           17
  MCI (25--28)                       8            6
  Mild (20--24)                      9            5
  Moderate (15--19)                  1            6
  Moderately Severe (11--15)         6            4

MMSE, Mini-Mental State Examination (range = 0--30; 0 = completely cognitively impaired 30 = completely cognitively intact). MCI, mild cognitive impairment.

Psychophysical {#sec0055}
--------------

Summaries of the psychophysical self-report data for males and females are in [Table 3](#jad-70-jad190142-t003){ref-type="table"}. Females reported mild and moderate pain at statistically significantly lower temperature values than did males (*p* \< 0.05, Cohen's *d* = 0.51--0.54). Males, on the other hand, rated the experience of moderate pain statistically significantly more unpleasant than did the females (*p* = 0.016, Cohen's *d* = 0.57).

###### 

Psychophysics of temperature thresholds necessary to produce warmth, mild pain, or moderate pain and unpleasantness ratings at each condition

                     Female (*n* = 38) Median \[IQR\]   Male (*n* = 38) Median \[IQR\]   Cohen's  
  ----------------- ---------------------------------- -------------------------------- --------- ------
  Temperature                                                                                     
    Warmth                     33 \[32,35\]                      33 \[32,36\]             0.139    0.34
    Mild pain                  36 \[35,40\]                      39 \[35,44\]             0.022    0.54
    Moderate pain              39 \[38,43\]                      44 \[37,46\]             0.029    0.51
  Unpleasantness                                                                                  
    Warmth                      0 \[0,1\]                         0 \[0,2\]               0.115    0.30
    Mild pain                   3 \[0,5\]                         4 \[1,6\]               0.140    0.33
    Moderate pain               5 \[2,8\]                         7 \[5,11\]              0.016    0.57

Temperature was measured in degrees Celsius (range = 30--55°C). Unpleasantness was measured by numerical descriptor scale (0 = neutral, 20 = extremely unpleasant).

![Affective Sensory and Unpleasantness Numerical Scale. Numerical descriptor scale used to measure affective unpleasantness and sensory intensity. Reprinted with permission from *Eur J Pain*, **9**, *Petzke F, Harris RE, Williams DA, Clauw DJ, Gracely RH*, Differences in unpleasantness induced by experimental pressure pain between patients with fibromyalgia and healthy controls. 325--335. Copyright (2005), with permission from JohnWiley and Sons.](jad-70-jad190142-g001){#jad-70-jad190142-g001}

Associations of MMSE with psychophysical reports {#sec0060}
------------------------------------------------

Associations of the participant MMSE scores with their psychophysical reports (temperature and unpleasantness) are summarized for the entire sample and by sex in [Table 4](#jad-70-jad190142-t004){ref-type="table"}. A statistically significant inverse association of MMSE with temperature reports at the warmth threshold was observed for both males and females (*r* = --0.33 and --0.41 respectively, *p* \< 0.05) with no statistically significant difference between them (*p* = 0.767). Thus, regardless of sex, temperatures at which a warmth threshold was reported increased as MMSE scores decreased. Minimal associations were detected between MMSE scores and temperature reports at either of the other two thresholds for both sex groups (*r* = --0.13 to --0.05, *p* \> 0.50, see [Table 4](#jad-70-jad190142-t004){ref-type="table"}).

###### 

Correlations of MMSE scores with temperature and unpleasantness ratings at each threshold level for the entire sample and within gender groups

                      Overall (N = 76)    Female (*n* = 38)     Male (*n* = 38)     Difference *p*^\*^
  ----------------- -------------------- -------------------- -------------------- --------------------
  Temperature            *r* (*p*)            *r* (*p*)            *R* (*p*)       
    Warmth           **--0.36 (0.001)**   **--0.41 (0.010)**   **--0.33 (0.044)**         0.767
    Mild pain          --0.09 (0.460)       --0.13 (0.442)       --0.07 (0.671)           0.959
    Moderate pain      --0.08 (0.482)       --0.05 (0.766)       --0.11 (0.508)           0.720
  Unpleasantness                                                                   
    Warmth             --0.01 (0.990)       --0.04 (0.833)        0.01 (0.953)            0.857
    Mild pain          --0.07 (0.543)        0.07 (0.698)        --0.19 (0.249)           0.265
    Moderate pain       0.03 (0.772)       **0.30 (0.072)**    **--0.20 (0.221)**       **0.033**

Associations of the participant MMSE scores with their psychophysical reports (temperature and unpleasantness). Skewed distributions were transformed to normal for Pearson correlations (r) and linear regressions. Warmth threshold: Both temperature and unpleasantness values were rank transformed. Mild and moderate pain thresholds: Unpleasantness values were square-root transformed. ^\*^Centered sex\*MMSE interaction effect after controlling for main effects of sex and MMSE in linear regression analysis.

There was a statistically significant difference between males and females in the direction of the association of MMSE scores with unpleasantness ratings at the moderate pain threshold (*p* = 0.033). In females, the direction of the association was that ratings of unpleasantness increased as MMSE scores increased (*r* = 0.30, *p* = 0.072). To the contrary, in males the direction of the association was reversed; ratings of unpleasantness at that threshold increased as MMSE scores decreased (*r* = --0.20, *p* = 0.221). Thus, while neither of the specific correlations within each sex group was statistically significant, the magnitude of the difference between them in terms of the direction (positive or inverse) was statistically significant (interaction term, *p* = 0.033). None of the other associations between MMSE scores and unpleasantness reports at either of the other two thresholds (warmth or mild pain) for both sex groups were statistically significant (*r* = --0.19 to +0.07, *p* \> 0.20) nor were any of the tests of difference between those correlations (see [Table 4](#jad-70-jad190142-t004){ref-type="table"}).

DISCUSSION {#sec0065}
==========

We found in both males and females that those with a lower global cognition rating required a higher temperature to elicit the perception of pain and males tended to report greater unpleasantness. This result parallels our previously reported pilot study \[[@ref024]\] from this sample in which males with AD only, reported pain as more unpleasant. This study extends these findings in individuals across the cognitive spectrum. In parent study, males reported pain as more unpleasant regardless of cognitive status. These results are important because they demonstrate that sex differences in the perception of pain might be present across the cognitive spectrum.

Our finding that a greater pain stimulus is required to elicit the perception of pain with worsening cognition agrees with several previous studies from our laboratory and others \[[@ref007]\]. As mentioned above, we have previously shown using the same methods described in this paper that people with a clinical diagnosis of AD demonstrated higher thermal thresholds for the detection of "warmth", "mild pain", and "moderate pain" \[[@ref023]\]. Others have found that people with AD demonstrated higher mechanical pressure pain thresholds and increased detection thresholds for electrical shock pain threshold \[[@ref013]\], respectively. Regarding sex effects on the detection of thermal pain stimuli unlike previous studies, the current study showed no difference between males and females in pain stimuli required to elicit the perception of pain. Interestingly, while controlling for covariates, the detection of thermal pain may be driven by possible depression (based on MMSE screening) in males.

Our results of the affective response to pain were unlike those reported for younger adults; males show greater pain-associated unpleasantness than females \[[@ref015]\]. The current study found evidence to suggest that in males worsening global cognitive function was associated with higher reports of unpleasantness in the presence of weak and moderate pain. This finding supports Benedetti and colleagues \[[@ref034]\], who reported increased tolerance to highly unpleasant evoked pain stimuli (electrical shock and ischemic arm pain) in people with worsening AD.

As an exploratory secondary analysis, there are some obvious limitations in the current study to consider when interpreting results. The parent study was not powered to detect sex differences, and the sample size was moderate. Other sensory modalities (e.g., somatosensory, auditory) may contribute to the overall pain experience which was not in the scope of this paper. As we have previously noted \[[@ref026]\], a perceptual matching paradigm was used rather than a fixed temperature for thermal sensory detection levels. This procedure may have impacted the pattern of findings for pain unpleasantness in unknown ways. To comply with IRB recommendation, we used the Method of Limits program on the Medoc Pathways Model so that the individual (regardless of cognition) was in control of the perceptual pain stopping point.

For this reason, we were unable to collect any perception above the rating of "moderate pain", specifically avoiding the perception of "severe pain" or the perception of "pain tolerance". This design was developed based on the mechanical pressure paradigm used by Cole and colleagues \[[@ref013]\] in their perceptual matching paradigm of people with AD. Despite these limitations, the current study adds to the limited number of clinical and experimental pain studies examining sex differences in altered pain response in people with cognitive impairment. Another strength of the design is that the authorship team includes authors with experience in the legal and ethical issues in pain research in people with cognitive impairment \[[@ref035]\].

The clinical relevance of these findings suggests that, in either sex, the diminished ability to detect pain could lead to an increase in adverse outcomes, such as an increase in the length of hospitalization \[[@ref036]\]. Additionally, the increased reporting of unpleasantness in males may increase the risk of suffering from pain in those with worsening cognition. Relative to cognitively healthy controls, people with worsening cognition generally have an altered response to clinical and experimental pain. Sex differences in pain reports compound the risk of increased pain in those with worsening cognition, especially when one-dimensional pain intensity scales are used that do not measure pain affect.

In summary, the current study found that sex differences in pain experiences may be present in older adults with varying degrees of cognition. Future studies are needed to replicate these results and should include an examination of the response to fixed temperatures and neurophysiological basis of sex differences in pain processing in a wide range of ages and across the spectrum of cognitive functioning. In consideration of mounting evidence, we continue to advocate that clinicians consider using a multi-dimensional sensory and unpleasantness pain tool in clinical practice as males and females may ultimately report pain intensity and pain unpleasantness differently, regardless of cognition. Using pain intensity measures only may predispose to suffering by not capturing an essential dimension of pain.
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